Featured Research

from universities, journals, and other organizations

Women Less Likely To Receive Heart Device Therapy But Survive With It Longer Than Men

Date:
November 27, 2005
Source:
Mayo Clinic
Summary:
Women with heart failure are less likely than men to receive cardiac resynchronization therapy (CRT) -- an implantable device shown to enhance quality of life for people with heart failure; yet women who get CRT live longer than men who get it, according to Mayo Clinic research presented today at the American Heart Association's Scientific Sessions 2005 in Dallas.

Women with heart failure are less likely than men to receive cardiac resynchronization therapy (CRT) -- an implantable device shown to enhance quality of life for people with heart failure; yet women who get CRT live longer than men who get it, according to Mayo Clinic research presented today at the American Heart Association's Scientific Sessions 2005 in Dallas.

Related Articles


The cases of all patients who underwent implantation of a CRT device at Mayo Clinic between 1999 and 2004 were reviewed to determine gender-specific referrals and evaluate how the patients fared with the therapy. A total of 373 patients were included; 82 percent were male. The average age was 69 for men and 65 for women.

Survival at five years for women (76 percent) was almost double that of the men (46 percent).

"Our data highlight a potentially important gender bias, in that fewer women, despite being eligible, are being referred for cardiac resynchronization therapy compared with a similar group of males," says Grace Lin, M.D., the lead author of the study. Dr. Lin practices at Mayo Clinic in Rochester, Minn. "It is another example in recent years of potential under-treatment of women with heart disease in this country. Whether such 'referral bias' is universal, however, deserves further study."

The study also found that device implantation success, complication rates and heart function improvement were similar in men and women. However, benefit of CRT, in terms of long-term survival, was significantly better in women.

"Gender referral bias needs to be addressed by further studies, since women with congestive heart failure who qualify for CRT may have equal or greater benefit than men," Dr. Lin says.



Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Women Less Likely To Receive Heart Device Therapy But Survive With It Longer Than Men." ScienceDaily. ScienceDaily, 27 November 2005. <www.sciencedaily.com/releases/2005/11/051126141742.htm>.
Mayo Clinic. (2005, November 27). Women Less Likely To Receive Heart Device Therapy But Survive With It Longer Than Men. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2005/11/051126141742.htm
Mayo Clinic. "Women Less Likely To Receive Heart Device Therapy But Survive With It Longer Than Men." ScienceDaily. www.sciencedaily.com/releases/2005/11/051126141742.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins